318 related articles for article (PubMed ID: 33231665)
1. Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic Malignancy.
Atkins JL; Pilling LC; Masoli JAH; Kuo CL; Shearman JD; Adams PC; Melzer D
JAMA; 2020 Nov; 324(20):2048-2057. PubMed ID: 33231665
[TBL] [Abstract][Full Text] [Related]
2. Hereditary Hemochromatosis Variant Associations with Incident Nonliver Malignancies: 11-Year Follow-up in UK Biobank.
Atkins JL; Pilling LC; Torti SV; Torti FM; Kuchel GA; Melzer D
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1780-1787. PubMed ID: 35709753
[TBL] [Abstract][Full Text] [Related]
3. Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: Associations in a large community cohort.
Pilling LC; Atkins JL; Melzer D
Hepatology; 2022 Dec; 76(6):1735-1745. PubMed ID: 35567766
[TBL] [Abstract][Full Text] [Related]
4. Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank.
Pilling LC; Tamosauskaite J; Jones G; Wood AR; Jones L; Kuo CL; Kuchel GA; Ferrucci L; Melzer D
BMJ; 2019 Jan; 364():k5222. PubMed ID: 30651232
[TBL] [Abstract][Full Text] [Related]
5. HFE genotype in patients with hemochromatosis and other liver diseases.
Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
[TBL] [Abstract][Full Text] [Related]
6. HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women.
Warne CD; Zaloumis SG; Bertalli NA; Delatycki MB; Nicoll AJ; McLaren CE; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ; Gurrin LC;
J Gastroenterol Hepatol; 2017 Apr; 32(4):797-802. PubMed ID: 27784128
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y homozygotes.
Barton JC; Barton JC; Adams PC
Ann Hepatol; 2019; 18(2):354-359. PubMed ID: 31056361
[TBL] [Abstract][Full Text] [Related]
8. Hemochromatosis Genetic Variants and Musculoskeletal Outcomes: 11.5-Year Follow-Up in the UK Biobank Cohort Study.
Banfield LR; Knapp KM; Pilling LC; Melzer D; Atkins JL
JBMR Plus; 2023 Oct; 7(10):e10794. PubMed ID: 37808392
[TBL] [Abstract][Full Text] [Related]
9. Hemochromatosis Mutations, Brain Iron Imaging, and Dementia in the UK Biobank Cohort.
Atkins JL; Pilling LC; Heales CJ; Savage S; Kuo CL; Kuchel GA; Steffens DC; Melzer D
J Alzheimers Dis; 2021; 79(3):1203-1211. PubMed ID: 33427739
[TBL] [Abstract][Full Text] [Related]
10. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
[TBL] [Abstract][Full Text] [Related]
11. Hereditary Hemochromatosis Associations with Frailty, Sarcopenia and Chronic Pain: Evidence from 200,975 Older UK Biobank Participants.
Tamosauskaite J; Atkins JL; Pilling LC; Kuo CL; Kuchel GA; Ferrucci L; Melzer D
J Gerontol A Biol Sci Med Sci; 2019 Feb; 74(3):337-342. PubMed ID: 30657865
[TBL] [Abstract][Full Text] [Related]
12. Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes.
Natarajan Y; Patel P; Chu J; Yu X; Hernaez R; El-Serag H; Kanwal F
Dig Dis Sci; 2023 Jan; 68(1):312-322. PubMed ID: 35790703
[TBL] [Abstract][Full Text] [Related]
13. HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study.
Pankow JS; Boerwinkle E; Adams PC; Guallar E; Leiendecker-Foster C; Rogowski J; Eckfeldt JH
Transl Res; 2008 Jul; 152(1):3-10. PubMed ID: 18593631
[TBL] [Abstract][Full Text] [Related]
14. Platelet counts in
Barton JC; Barton JC; Acton RT
Platelets; 2023 Dec; 34(1):2217933. PubMed ID: 37260121
[TBL] [Abstract][Full Text] [Related]
15. Association of Genetic Variant Linked to Hemochromatosis With Brain Magnetic Resonance Imaging Measures of Iron and Movement Disorders.
Loughnan R; Ahern J; Tompkins C; Palmer CE; Iversen J; Thompson WK; Andreassen O; Jernigan T; Sugrue L; Dale A; Boyle MET; Fan CC
JAMA Neurol; 2022 Sep; 79(9):919-928. PubMed ID: 35913729
[TBL] [Abstract][Full Text] [Related]
16. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.
Adams PC; Speechley M; Barton JC; McLaren CE; McLaren GD; Eckfeldt JH
Hepatology; 2012 Jun; 55(6):1722-6. PubMed ID: 22183642
[TBL] [Abstract][Full Text] [Related]
17. White blood cells and subtypes in HFE p.C282Y and wild-type homozygotes in the Hemochromatosis and Iron Overload Screening Study.
Barton JC; Barton JC; Acton RT
Blood Cells Mol Dis; 2017 Mar; 63():9-14. PubMed ID: 27915113
[TBL] [Abstract][Full Text] [Related]
18. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
19. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
[TBL] [Abstract][Full Text] [Related]
20.
Sandnes M; Vorland M; Ulvik RJ; Reikvam H
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440336
[No Abstract] [Full Text] [Related]
[Next] [New Search]
